Peak Bio, Inc. Operating Expenses
Peak Bio, Inc. reported Operating Expenses of $1.49 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2024-11-12
- Peak Bio, Inc. operating expenses for the quarter ending 2024-09-30 was $1.49M, a 35.39% decline year-over-year.
- Peak Bio, Inc. operating expenses for the quarter ending 2024-06-30 was $1.39M, a 47.92% decline year-over-year.
- Peak Bio, Inc. operating expenses for the quarter ending 2024-03-31 was $2.20M, a 69.51% decline year-over-year.
- Peak Bio, Inc. operating expenses for the quarter ending 2023-12-31 was $1.22M, a 77.67% decline year-over-year.
- Peak Bio, Inc. operating expenses for fiscal 2023 was $13.43M, a 7.85% increase from fiscal 2022.
- Peak Bio, Inc. operating expenses for fiscal 2022 was $12.46M, a 29.83% increase from fiscal 2021.
- Peak Bio, Inc. operating expenses for fiscal 2021 was $9.59M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2024-09-30 | $1.49M 10-Q · filed 2024-11-12 | $2.88M derived: sum of 2 quarters · filed 2024-11-12 | $5.09M 10-Q · filed 2024-11-12 | $6.31M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | $1.39M 10-Q · filed 2024-08-23 | $3.60M 10-Q · filed 2024-08-23 | $4.82M derived: sum of 3 quarters · filed 2024-08-23 | $7.13M derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-03-31 | $2.20M 10-Q · filed 2024-08-23 | $3.43M derived: sum of 2 quarters · filed 2024-08-23 | $5.74M derived: sum of 3 quarters · filed 2024-11-12 | $8.41M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-12-31 | $1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $3.53M derived: sum of 2 quarters · filed 2024-11-12 | $6.20M derived: sum of 3 quarters · filed 2024-11-12 | $13.43M 10-K · filed 2024-08-06 |
| 2023-09-30 | $2.31M 10-Q · filed 2024-11-12 | $4.98M derived: sum of 2 quarters · filed 2024-11-12 | $12.21M 10-Q · filed 2024-11-12 | $17.68M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $2.67M 10-Q · filed 2024-08-23 | $9.90M 10-Q · filed 2024-08-23 | $15.37M derived: sum of 3 quarters · filed 2024-08-23 | $17.25M derived: sum of 4 quarters · filed 2024-08-23 |
| 2023-03-31 | $7.23M 10-Q · filed 2024-08-23 | $12.70M derived: sum of 2 quarters · filed 2024-08-23 | $14.58M derived: sum of 3 quarters · filed 2024-08-23 | $17.31M derived: sum of 4 quarters · filed 2024-08-23 |
| 2022-12-31 | $5.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $7.35M derived: sum of 2 quarters · filed 2024-08-06 | $10.08M derived: sum of 3 quarters · filed 2024-08-06 | $12.46M 10-K · filed 2024-08-06 |
| 2022-09-30 | $1.88M 10-Q · filed 2024-06-25 | $4.61M derived: sum of 2 quarters · filed 2024-06-25 | $6.99M 10-Q · filed 2024-06-25 | |
| 2022-06-30 | $2.73M 10-Q · filed 2023-08-18 | $5.11M 10-Q · filed 2023-08-18 | ||
| 2022-03-31 | $2.38M 10-Q · filed 2023-07-12 | |||
| 2021-12-31 | $9.59M 10-K · filed 2023-06-29 |